• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue2

Malat1 RNA Genetic Factor and T1 Bladder Cancer

    Vladimir F. Kulikovsky Viktor K. Gostishchev Alexander F. Chernousov Pavel G. Osipov Andrey L. Yarosh Uriy A. Hoschenko Olesya I. Lokteva Andrey A. Beresh

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 141-145

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Bladder cancer is the most common malignant tumor of the urinary tract. This disease
has a pronounced tendency to relapse and progress, is characterized by a severe course
and a high degree of disability. Non-invasive bladder cancer - superficial tumors of the
mucous membrane of the bladder with possible germination in the submucosal layer,
but without muscle invasion (pTa and pT1). Invasive bladder cancer - with germination in
the muscle layer (≥рТ2). Currently, there is an extensive literature on genetic data with
RMP T2-T4, but there is not enough information about the early form of RMP - T1. It
was discovered that almost 90% of the human genome is actively transcribed, while
only 2% are protein-coding genes, and the majority of the transcripts are non-coding
RNAs. Molecules of non-coding RNA, depending on their size, are divided by length. A
lot of data has been published regarding the effect of short variants of these molecules
on the development of oncopathology by inhibiting mRNA expression. At the same
time, we did not find large studies devoted to the study of the influence of long noncoding
RNAs. Also now, the MALAT1 dnaRNA is attracting the attention of scientists.
Concurrently, researchers are particularly interested in studying the relationship of single
nucleotide polymorphisms of the MALAT1 gene with the appearance of
oncopathologies of different localization, as well as the study of its association with
different characteristics and stages of the tumor process. In this study, we collected
overview data regarding the possible association of rs 3200401 polymorphism of the
MALAT1 gene in patients with a single focus and multifocal bladder cancer stage T1.
Keywords:
    bladder cancer genetic polymorphism non-coding RNA multifocality
  • PDF (692 K)
  • XML
(2020). Malat1 RNA Genetic Factor and T1 Bladder Cancer. European Journal of Molecular & Clinical Medicine, 7(2), 141-145.
Vladimir F. Kulikovsky; Viktor K. Gostishchev; Alexander F. Chernousov; Pavel G. Osipov; Andrey L. Yarosh; Uriy A. Hoschenko; Olesya I. Lokteva; Andrey A. Beresh. "Malat1 RNA Genetic Factor and T1 Bladder Cancer". European Journal of Molecular & Clinical Medicine, 7, 2, 2020, 141-145.
(2020). 'Malat1 RNA Genetic Factor and T1 Bladder Cancer', European Journal of Molecular & Clinical Medicine, 7(2), pp. 141-145.
Malat1 RNA Genetic Factor and T1 Bladder Cancer. European Journal of Molecular & Clinical Medicine, 2020; 7(2): 141-145.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 115
  • PDF Download: 201
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus